Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

22 Apr 2010 07:00

RNS Number : 5867K
Persimmon PLC
22 April 2010
 



INTERIM MANAGEMENT STATEMENT

THURSDAY 22 APRIL 2010

 

 

 

Persimmon plc is holding its Annual General Meeting at 12 noon today at York Racecourse where the following comments will be made regarding current trading, financial performance and the outlook for the financial year. This statement, which supplements the update given at the time of our 2009 results, covers the period from 1 January 2010 to the date of this announcement and constitutes Persimmon Plc's first Interim Management Statement in 2010.

 

Since we announced our results for the year ended 31 December 2009 on 2 March 2010 weekly sales volumes have remained consistent despite a backdrop of continued uncertainty regarding the wider economic outlook and the forthcoming General Election. Total sales, including legal completions to date, are c. 20% ahead of last year at c. £1.15 billion. Sales volumes are c. 11% ahead including a higher content of private sales and prices remain firm. Encouragingly, weekly visitors per site are constant with good conversion to reservations. Cancellation rates remain at historically low levels.

 

Maintaining an appropriate level of sales while focusing on achieving price growth in all regions continues to form the basis of our current strategy. Margin improvement remains a priority.

 

We are opening new developments in line with our planned investment programme while closely monitoring working capital levels across the business. We are currently operating from c. 375 sites having opened 50 new sites through the first quarter of the year in line with our expectations. We have a further 40 sites which we currently intend to start during the second quarter. These new site openings will provide us with the opportunity to secure some further price improvement and maintain sales momentum.

 

We continue to focus on minimising build costs and on the strict control of overhead costs.

 

Against this background of trading we are carefully selecting land opportunities for investment. Whilst we continue to apply strict criteria to land purchases, we have recently acquired some excellent sites including some from our strategic land portfolio upon which we have now received residential planning consents. This new land will generate higher margins as development commences during the next 12 months.

 

At the end of March, the point in the financial year where we approach our traditional peak seasonal working capital requirements, net borrowings were at c. £265 million (31 March 2009: £680 million). Debt levels are expected to reduce further as the year progresses.

 

With margin improvement underway, cash generation remaining robust, and our high quality consented and strategic landbanks, we are in a strong position in the UK housing market to deliver profitable growth.

 

We will give a further update on trading on Tuesday 6 July 2010 following the half year end.

 

For further information, please contact:

 

 

M:Communications

Edward Orlebar

Tel: +44 (0) 7738 724 630

Charlotte McMullen

Tel: +44 (0) 207 920 2349

Marylène Guernier

Tel: +44 (0) 7776 303 788

 

Persimmon plc

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Tel: +44 (0) 1904 642199

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAVNRROASUAR
Date   Source Headline
23rd Jun 201710:05 amRNSHolding(s) in Company
1st Jun 20172:42 pmRNSBlock listing Interim Review
1st Jun 20172:39 pmRNSTotal Voting Rights
31st May 201710:03 amRNSHolding(s) in Company
12th May 20175:30 pmRNSHolding(s) in Company
4th May 20174:19 pmRNSHolding(s) in Company
2nd May 201710:45 amRNSTotal Voting Rights
27th Apr 20174:37 pmRNSAGM Statement
27th Apr 20177:00 amRNSTrading Update
11th Apr 201712:52 pmRNSAdditional Listing
5th Apr 20172:05 pmRNSDirector/PDMR Shareholding
3rd Apr 20174:57 pmRNSTotal Voting Rights
31st Mar 201712:31 pmRNSDirector/PDMR Shareholding
20th Mar 20171:58 pmRNSAnnual Financial Report
8th Mar 20174:03 pmRNSDirector/PDMR Shareholding
8th Mar 201711:49 amRNSDirector/PDMR Shareholding
7th Mar 20174:45 pmRNSDirector/PDMR Shareholding
1st Mar 20173:42 pmRNSDirector/PDMR Shareholding
1st Mar 20171:16 pmRNSTotal Voting Rights
27th Feb 20177:00 amRNSFinal Results
23rd Feb 20171:38 pmRNSDirectorate Change
1st Feb 20173:54 pmRNSTotal Voting Rights
31st Jan 20175:20 pmRNSHolding(s) in Company
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20176:12 pmRNSHolding(s) in Company
3rd Jan 201711:13 amRNSTotal Voting Rights
21st Dec 201610:09 amRNSHolding(s) in Company
15th Dec 201612:36 pmRNSHolding(s) in Company
2nd Dec 20164:14 pmRNSBlock listing Interim Review
1st Dec 201610:33 amRNSHolding(s) in Company
1st Dec 201610:26 amRNSTotal Voting Rights
1st Dec 20167:00 amRNSHolding(s) in Company
29th Nov 201610:35 amRNSHolding(s) in Company
25th Nov 20165:21 pmRNSHolding(s) in Company
22nd Nov 20161:38 pmRNSHolding(s) in Company
21st Nov 20161:32 pmRNSHolding(s) in Company
2nd Nov 20167:00 amRNSTrading Statement
1st Nov 201612:34 pmRNSTotal Voting Rights
19th Sep 201611:10 amRNSChange of date of 2016 Full Year Results
1st Sep 20163:32 pmRNSTotal Voting Rights
23rd Aug 20167:00 amRNSHalf-year results for 6 months ended 30 June 2016
1st Aug 20162:35 pmRNSTotal Voting Rights
11th Jul 20163:33 pmRNSDirector Declaration
5th Jul 20169:58 amRNSDirector Declaration
5th Jul 20167:00 amRNSTrading Update
1st Jul 201610:37 amRNSTotal Voting Rights
29th Jun 20165:58 pmRNSEBT Share Purchase
1st Jun 201611:31 amRNSTotal Voting Rights
1st Jun 201611:05 amRNSBlock listing Interim Review
3rd May 201610:17 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.